Linda Sullivan, Co-Founder and President of the Metrics Champion Consortium (MCC), published a peer-reviewed article in the Applied Clinical Trials Magazine. The article, ‘The Current Status of Risk-Based Monitoring’ analyzes the results of a 2013 survey conducted by the MCC. According to the survey results published in 2014, the top three reasons for RMB use are reducing monitoring costs, improving data quality, and improving quality oversight.
This informative article, published in March 2015 is not Linda’s first article in Applied Clinical Trials magazine. She has written on a variety of topics, ranging from protocol amendments to percentage budget variance metrics. Applied Clinical Trials magazine is an online, peer-reviewed publication dedicated to providing information on managing clinical trials and related subjects.